Danaher Chairman to Sell 15M Shares | GenomeWeb

Danaher Chairman to Sell 15M Shares

Oct 25, 2012

|

NEW YORK (GenomeWeb News) – Danaher today said that Steven Rales, its chairman of the board, will sell 15 million shares of Danaher common stock under SEC Rule 144.

The rule governs the public resale of restricted and control securities.

Danaher said that Rales is selling the shares in connection with his personal financial and estate planning. Following the sale, he will continue to hold more than 43 million shares of Danaher's outstanding common stock. Danaher has around 692.7 million total shares outstanding.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Threats of Synthetic Biology

A new report highlights the potential threats posed by advances in synthetic biology, NPR reports.

Deletion Is Hard to Do

A Bloomberg reporter tried to get her genetic data deleted, but found it's not so simple to do.

So Just How Many Are There?

Johns Hopkins University's Steven Salzberg and his colleagues have come up with a new estimate for the number of human genes, Nature News reports.

This Week in Genome Research

In Genome Research this week: study of intra-tumor heterogeneity, workflow resources for EPIGEN-Brazil, and more.